PFKFB3 and cancer: Considering the synergy between PBKFB3i and DNA-damaging platinum drugs (Figure 1A–C) and the previously described relocation of PFKFB3 into nuclear foci at DNA damage sites upon induction of DNA DSBs [25], we next determined PFKFB3 intracellular localization upon cisplatin treatment during cancer transformation.